Alzheimer's Disease Trial, Recruiting (NCT04690660)

Alzheimer's Disease Trial, Recruiting NCT04690660 Sponsor: University Hospital, Basel, Switzerland Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04690660 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women who developed high blood pressure during pregnancy
Women who developed high blood pressure after giving birth (blood pressure readings of 140 or higher on the top number and/or 90 or higher on the bottom number, or who are taking blood pressure medication within the first 14 days after delivery)
Women who had high blood pressure before becoming pregnant
Women who are already taking medication to lower their blood pressure

Who may not be able to join:

Women who gave birth more than 14 days before enrolling in the trial
Women who are unable or unwilling to give consent to participate, those who face language barriers, or those who may not be able to fully understand what the study involves

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thenral Socrates, Dr. med., Medical Outpatient Department and Hypertension Clinic, University Hospital BaselUni

Phone: +41 61 328 6647

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04690660

Sponsor: University Hospital, Basel, Switzerland

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: +41 61 328 6647

More information: https://clinicaltrials.gov/study/NCT04690660

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women who developed high blood pressure during pregnancy
Women who developed high blood pressure after giving birth (blood pressure readings of 140 or higher on the top number and/or 90 or higher on the bottom number, or who are taking blood pressure medication within the first 14 days after delivery)
Women who had high blood pressure before becoming pregnant
Women who are already taking medication to lower their blood pressure

Who may not be able to join:

Women who gave birth more than 14 days before enrolling in the trial
Women who are unable or unwilling to give consent to participate, those who face language barriers, or those who may not be able to fully understand what the study involves

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Basel, Switzerland

Registry

ClinicalTrials.gov

Start date

4 June 2020

Est. completion

1 May 2030

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Frequency of persistent hypertension defined by 24 hours BP measurement; Frequency of persistent hypertension defined by office blood pressure measurement (OBPM, AOBPM); Frequency of microalbuminuria; Frequency of damage to the retina of the eyes (retinopathy); Signs of hypertensive heart disease; Frequency of dyslipidemia; Frequency of prediabetes/diabetes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov